Ceftriaxone-Darnitsa
Systemic antibacterial agents. Other -lactam antibiotics. Third-generation cephalosporins. CeftriaxoneCeftriaxone-Darnitsa should be used for the treatment of infections whose pathogens are sensitive to ceftriaxone:
– pulmonary tract infections, especially pneumonia, as well as ear, throat, and nose infections;
– infections of the abdominal organs (peritonitis, biliary and gastrointestinal tract infections);
– renal and urinary tract infections;
– genital infections including gonorrhea;
– sepsis;
– Bone, joint, soft tissue, skin, and wound infections;
– infections in patients with weakened immunity;
– meningitis;
– disseminated Lyme disease (stage 2 and 3).
Postoperative prevention of infections in gastrointestinal tract, biliary tract, urinary tract surgeries, and during gynaecological procedures, but only in cases of potential or known contamination.
When the medicine is prescribed, the official guidelines for antibiotic therapy and, in particular, the recommendations for the prevention of antibiotic resistance should be followed.
Characteristics of the productу:
Release formPowder for injection
ChildrenAllowed
PregnantWith caution
NursingContraindicated
Release categoryPrescription medication
AllergicsWith caution
DriversWith caution
Temperature storage conditionsNot higher than 25 °С
- Qualitative and quantitative composition
- Pharmaceutical form
- Pharmacotherapeutic group
- Pharmacological properties
- Therapeutic indications
- Indications
- Contraindications
- Interaction with other medicinal products and other forms of interaction
- Special warnings and precautions for use
- Fertility, pregnancy and lactation
- Effects on ability to drive and use machines
- Posology and method of administration
- Children
- Overdose
- Undesirable effects
- Shelf life
- Special precaution for storage
- Incompatibilities
- Nature and contents of container
- Category of release
- Manufacturer
- The manufacturer's location and address of the place of business
- Date of revision of the text